# Quanex Building Products CORP: financial statements, quarterly

NX · NYSE · CIK 1423221 · [Materials](/sectors/materials.md) · fiscal year ends Oct 31

Pages: [Overview](/companies/nx.md) · [Financials](/companies/nx/financials.md) · [Filings](/companies/nx/filings.md) · [Insiders](/companies/nx/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/nx/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-10-31) | Q1 FY2024 (2024-01-31) | Q2 FY2024 (2024-04-30) | Q3 FY2024 (2024-07-31) | Q4 FY2024 (2024-10-31) | Q1 FY2025 (2025-01-31) | Q2 FY2025 (2025-04-30) | Q3 FY2025 (2025-07-31) | Q4 FY2025 (2025-10-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [295 d](/filings/0001423221-25-000100.md) | [239](/filings/0001423221-25-000003.md) | [266](/filings/0001423221-25-000007.md) | [280](/filings/0001423221-25-000024.md) | [492 d](/filings/0001423221-25-000100.md) | [400](/filings/0001423221-26-000017.md) | [452](/filings/0001423221-26-000034.md) | [495](/filings/0001423221-26-000048.md) | [490 d](/filings/0001423221-25-000100.md) | [409](/filings/0001423221-26-000017.md) | [462](/filings/0001423221-26-000034.md) | [502](/filings/0001423221-26-000048.md) |
| Cost of revenue | $m | [215 d](/filings/0001423221-25-000100.md) | [188](/filings/0001423221-25-000003.md) | [200](/filings/0001423221-25-000007.md) | [209](/filings/0001423221-25-000024.md) | [375 d](/filings/0001423221-25-000100.md) | [308](/filings/0001423221-26-000017.md) | [321](/filings/0001423221-26-000034.md) | [357](/filings/0001423221-26-000048.md) | [352 d](/filings/0001423221-25-000100.md) | [311](/filings/0001423221-26-000017.md) | [345](/filings/0001423221-26-000034.md) | [360](/filings/0001423221-26-000048.md) |
| Selling, general and administrative | $m | [29.3 d](/filings/0001423221-25-000100.md) | [32.4](/filings/0001423221-25-000003.md) | [34.7](/filings/0001423221-25-000007.md) | [36.5](/filings/0001423221-25-000024.md) | [86.9 d](/filings/0001423221-25-000100.md) | [66.7](/filings/0001423221-26-000017.md) | [70.3](/filings/0001423221-26-000034.md) | [71.3](/filings/0001423221-26-000048.md) | [69.0 d](/filings/0001423221-25-000100.md) | [71.4](/filings/0001423221-26-000017.md) | [74.4](/filings/0001423221-26-000034.md) | [70.8](/filings/0001423221-26-000048.md) |
| Operating income | $m | [39.5 d](/filings/0001423221-25-000100.md) | [7.9](/filings/0001423221-25-000003.md) | [20.6](/filings/0001423221-25-000007.md) | [23.4](/filings/0001423221-25-000024.md) | [2.8 d](/filings/0001423221-25-000100.md) | [(7.0)](/filings/0001423221-26-000017.md) | [40.9](/filings/0001423221-26-000034.md) | [(271)](/filings/0001423221-26-000048.md) | [42.9 d](/filings/0001423221-25-000100.md) | [2.9](/filings/0001423221-26-000017.md) | [18.7](/filings/0001423221-26-000034.md) | [46.5](/filings/0001423221-26-000048.md) |
| Interest expense | $m | [1.6 d](/filings/0001423221-25-000100.md) | [1.1](/filings/0001423221-25-000003.md) | [1.0](/filings/0001423221-25-000007.md) | [0.9](/filings/0001423221-25-000024.md) | [17.7 d](/filings/0001423221-25-000100.md) | [14.2](/filings/0001423221-26-000017.md) | [13.9](/filings/0001423221-26-000034.md) | [14.2](/filings/0001423221-26-000048.md) | [13.5 d](/filings/0001423221-25-000100.md) | [12.4](/filings/0001423221-26-000017.md) | [12.0](/filings/0001423221-26-000034.md) | [12.0](/filings/0001423221-26-000048.md) |
| Income tax | $m | [4.4 d](/filings/0001423221-25-000100.md) | [1.6](/filings/0001423221-25-000003.md) | [4.3](/filings/0001423221-25-000007.md) | [6.7](/filings/0001423221-25-000024.md) | [(3.6) d](/filings/0001423221-25-000100.md) | [(5.1)](/filings/0001423221-26-000017.md) | [6.3](/filings/0001423221-26-000034.md) | [(8.2)](/filings/0001423221-26-000048.md) | [15.1 d](/filings/0001423221-25-000100.md) | [0.2](/filings/0001423221-26-000017.md) | [3.8](/filings/0001423221-26-000034.md) | [7.9](/filings/0001423221-26-000048.md) |
| Net income | $m | [27.4 d](/filings/0001423221-25-000100.md) | [6.2](/filings/0001423221-25-000024.md) | [15.4](/filings/0001423221-25-000024.md) | [25.4](/filings/0001423221-25-000024.md) | [(13.9) d](/filings/0001423221-25-000100.md) | [(14.9)](/filings/0001423221-26-000048.md) | [20.5](/filings/0001423221-26-000048.md) | [(276)](/filings/0001423221-26-000048.md) | [19.6 d](/filings/0001423221-25-000100.md) | [(4.1)](/filings/0001423221-26-000048.md) | [3.4](/filings/0001423221-26-000048.md) | [26.5](/filings/0001423221-26-000048.md) |
| Diluted EPS | $ per share | not reported | [0.19](/filings/0001423221-25-000003.md) | [0.46](/filings/0001423221-25-000007.md) | [0.77](/filings/0001423221-25-000024.md) | not reported | [(0.32)](/filings/0001423221-26-000017.md) | [0.44](/filings/0001423221-26-000034.md) | [(6.04)](/filings/0001423221-26-000048.md) | not reported | [(0.09)](/filings/0001423221-26-000017.md) | [0.07](/filings/0001423221-26-000034.md) | [0.58](/filings/0001423221-26-000048.md) |
| Basic EPS | $ per share | not reported | [0.19](/filings/0001423221-25-000003.md) | [0.47](/filings/0001423221-25-000007.md) | [0.77](/filings/0001423221-25-000024.md) | not reported | [(0.32)](/filings/0001423221-26-000017.md) | [0.44](/filings/0001423221-26-000034.md) | [(6.04)](/filings/0001423221-26-000048.md) | not reported | [(0.09)](/filings/0001423221-26-000017.md) | [0.07](/filings/0001423221-26-000034.md) | [0.58](/filings/0001423221-26-000048.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold, us-gaap:CostOfRevenue
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-10-31) | Q1 FY2024 (2024-01-31) | Q2 FY2024 (2024-04-30) | Q3 FY2024 (2024-07-31) | FY2024 (2024-10-31) | Q1 FY2025 (2025-01-31) | Q2 FY2025 (2025-04-30) | Q3 FY2025 (2025-07-31) | FY2025 (2025-10-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [58.5](/filings/0001423221-24-000015.md) | [44.4](/filings/0001423221-24-000006.md) | [56.1](/filings/0001423221-24-000009.md) | [94.0](/filings/0001423221-24-000012.md) | [97.7](/filings/0001423221-25-000100.md) | [50.0](/filings/0001423221-25-000003.md) | [62.6](/filings/0001423221-25-000007.md) | [66.3](/filings/0001423221-25-000024.md) | [76.0](/filings/0001423221-26-000048.md) | [62.3](/filings/0001423221-26-000017.md) | [63.7](/filings/0001423221-26-000034.md) | [62.1](/filings/0001423221-26-000048.md) |
| Current assets | $m | [274](/filings/0001423221-24-000015.md) | [253](/filings/0001423221-24-000006.md) | [264](/filings/0001423221-24-000009.md) | [301](/filings/0001423221-24-000012.md) | [611](/filings/0001423221-25-000100.md) | [548](/filings/0001423221-25-000003.md) | [588](/filings/0001423221-25-000007.md) | [583](/filings/0001423221-25-000024.md) | [574](/filings/0001423221-26-000048.md) | [569](/filings/0001423221-26-000017.md) | [604](/filings/0001423221-26-000034.md) | [602](/filings/0001423221-26-000048.md) |
| Total assets | $m | [831](/filings/0001423221-24-000015.md) | [813](/filings/0001423221-24-000006.md) | [837](/filings/0001423221-24-000009.md) | [872](/filings/0001423221-24-000012.md) | [2,320](/filings/0001423221-25-000100.md) | [2,220](/filings/0001423221-25-000003.md) | [2,308](/filings/0001423221-25-000007.md) | [1,973](/filings/0001423221-25-000024.md) | [1,968](/filings/0001423221-26-000048.md) | [1,978](/filings/0001423221-26-000017.md) | [1,993](/filings/0001423221-26-000034.md) | [1,969](/filings/0001423221-26-000048.md) |
| Current liabilities | $m | [135](/filings/0001423221-24-000015.md) | [111](/filings/0001423221-24-000006.md) | [119](/filings/0001423221-24-000009.md) | [128](/filings/0001423221-24-000012.md) | [273](/filings/0001423221-25-000100.md) | [229](/filings/0001423221-25-000003.md) | [244](/filings/0001423221-25-000007.md) | [265](/filings/0001423221-25-000024.md) | [282](/filings/0001423221-26-000048.md) | [246](/filings/0001423221-26-000017.md) | [265](/filings/0001423221-26-000034.md) | [270](/filings/0001423221-26-000048.md) |
| Total liabilities | $m | [286](/filings/0001423221-24-000015.md) | [258](/filings/0001423221-24-000006.md) | [271](/filings/0001423221-24-000009.md) | [278](/filings/0001423221-24-000012.md) | [1,309](/filings/0001423221-25-000100.md) | [1,248](/filings/0001423221-25-000003.md) | [1,307](/filings/0001423221-25-000007.md) | [1,255](/filings/0001423221-25-000024.md) | [1,242](/filings/0001423221-26-000048.md) | [1,248](/filings/0001423221-26-000017.md) | [1,266](/filings/0001423221-26-000034.md) | [1,223](/filings/0001423221-26-000048.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [546](/filings/0001423221-25-000100.md) | [555](/filings/0001423221-25-000024.md) | [566](/filings/0001423221-25-000024.md) | [594](/filings/0001423221-25-000024.md) | [1,011](/filings/0001423221-26-000048.md) | [972](/filings/0001423221-26-000048.md) | [1,002](/filings/0001423221-26-000048.md) | [717](/filings/0001423221-26-000048.md) | [726](/filings/0001423221-26-000048.md) | [730](/filings/0001423221-26-000048.md) | [727](/filings/0001423221-26-000048.md) | [745](/filings/0001423221-26-000048.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-10-31) | Q1 FY2024 (2024-01-31) | Q2 FY2024 (2024-04-30) | Q3 FY2024 (2024-07-31) | Q4 FY2024 (2024-10-31) | Q1 FY2025 (2025-01-31) | Q2 FY2025 (2025-04-30) | Q3 FY2025 (2025-07-31) | Q4 FY2025 (2025-10-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [44.5 d](/filings/0001423221-25-000100.md) | [3.9](/filings/0001423221-25-000003.md) | [33.1 d](/filings/0001423221-25-000007.md) | [46.4 d](/filings/0001423221-25-000024.md) | [5.5 d](/filings/0001423221-25-000100.md) | [(12.5)](/filings/0001423221-26-000017.md) | [28.5 d](/filings/0001423221-26-000034.md) | [60.7 d](/filings/0001423221-26-000048.md) | [88.3 d](/filings/0001423221-25-000100.md) | [(20.2)](/filings/0001423221-26-000017.md) | [18.9 d](/filings/0001423221-26-000034.md) | [58.6 d](/filings/0001423221-26-000048.md) |
| Capital expenditure | $m | [14.9 d](/filings/0001423221-25-000100.md) | [9.6](/filings/0001423221-25-000003.md) | [7.6 d](/filings/0001423221-25-000007.md) | [6.3 d](/filings/0001423221-25-000024.md) | [13.7 d](/filings/0001423221-25-000100.md) | [11.6](/filings/0001423221-26-000017.md) | [14.9 d](/filings/0001423221-26-000034.md) | [14.5 d](/filings/0001423221-26-000048.md) | [21.6 d](/filings/0001423221-25-000100.md) | [11.3](/filings/0001423221-26-000017.md) | [11.0 d](/filings/0001423221-26-000034.md) | [10.7 d](/filings/0001423221-26-000048.md) |
| Dividends paid | $m | [2.7 d](/filings/0001423221-25-000100.md) | [2.6](/filings/0001423221-25-000003.md) | [2.6 d](/filings/0001423221-25-000007.md) | [2.6 d](/filings/0001423221-25-000024.md) | [4.0 d](/filings/0001423221-25-000100.md) | [3.8](/filings/0001423221-26-000017.md) | [3.7 d](/filings/0001423221-26-000034.md) | [3.7 d](/filings/0001423221-26-000048.md) | [3.7 d](/filings/0001423221-25-000100.md) | [3.6](/filings/0001423221-26-000017.md) | [3.6 d](/filings/0001423221-26-000034.md) | [3.6 d](/filings/0001423221-26-000048.md) |
| Share repurchases | $m | [0.0 d](/filings/0001423221-25-000100.md) | [0.0](/filings/0001423221-25-000003.md) | [0.0 d](/filings/0001423221-25-000007.md) | [0.0 d](/filings/0001423221-25-000024.md) | [0.0 d](/filings/0001423221-25-000100.md) | [3.7](/filings/0001423221-26-000017.md) | [23.5 d](/filings/0001423221-26-000034.md) | [2.1 d](/filings/0001423221-26-000048.md) | [3.1 d](/filings/0001423221-25-000100.md) | [0.0](/filings/0001423221-26-000017.md) | [0.0 d](/filings/0001423221-26-000034.md) | [1.7 d](/filings/0001423221-26-000048.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-01-31) | Q2 FY2023 (2023-04-30) | Q3 FY2023 (2023-07-31) | Q1 FY2024 (2024-01-31) | Q2 FY2024 (2024-04-30) | Q3 FY2024 (2024-07-31) | Q1 FY2025 (2025-01-31) | Q2 FY2025 (2025-04-30) | Q3 FY2025 (2025-07-31) | Q1 FY2026 (2026-01-31) | Q2 FY2026 (2026-04-30) | Q3 FY2026 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [33.1](/filings/0001423221-24-000006.md) | [33.0](/filings/0001423221-24-000009.md) | [32.9](/filings/0001423221-24-000012.md) | [33.0](/filings/0001423221-25-000003.md) | [33.1](/filings/0001423221-25-000007.md) | [33.1](/filings/0001423221-25-000024.md) | [47.0](/filings/0001423221-26-000017.md) | [46.6](/filings/0001423221-26-000034.md) | [45.7](/filings/0001423221-26-000048.md) | [45.5](/filings/0001423221-26-000017.md) | [45.7](/filings/0001423221-26-000034.md) | [45.6](/filings/0001423221-26-000048.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 45,826,208 at 2026-08-28, from the cover of the [10-Q filed 2026-09-04](/filings/0001423221-26-000048.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:39 ET. No prices; not investment advice.